{"data":{"responsecode":"000","responsemsg":"","quote":{"hi":"1.900","rs_stock_flag":false,"fiscal_year_end":"31 Dec 2024","hist_closedate":"25 Sep 2025","replication_method":null,"amt_os":"1,386,638,336","primaryexch":"HKEX","ric":"3681.HK","product_subtype":null,"db_updatetime":"26 Sep 2025 18:38","mkt_cap_u":"B","am_u":"M","ew_sub_right":"","secondary_listing":false,"ew_amt_os_cur":null,"ccy":"HKD","management_fee":"","ew_underlying_code":null,"trdstatus":"N","nav":"","original_offer_price":"","issue":"","asset_class":null,"eps":0.0,"inline_upper_strike_price":"","sedol":"BKLGNM9","am":"17.74","iv":"","ew_strike":"","as":"1.780","geographic_focus":null,"incorpin":"Hong Kong","etp_baseCur":null,"ew_amt_os":"","bd":"1.760","registrar":"Computershare Hong Kong Investor Services Ltd.","depositary":null,"exotic_type":null,"callput_indicator":null,"primary_market":null,"underlying_index":null,"lot":"300","update_time":"2025-09-26 10:38:37.0","lo52":"0.800","shares_issued_date":"31 Aug 2025","premium":"","strike_price_ccy":null,"yield":"","vo_u":"M","base_currency":null,"coupon":"","expiry_date":"","chairman":"Shui On Leung","underlying_ric":"3681.HK","hi52":"3.760","issuer_name":"SinoMab BioScience Ltd. - B","h_share_flag":false,"ew_sub_per_from":"","div_yield":"","interest_payment_date":"-","updatetime":"26 Sep 2025 16:08","aum_date":"","lo":"1.750","mkt_cap":"2.44","f_aum_hkd":null,"ew_sub_per_to":"","ls":"1.760","nav_date":"","csic_classification":null,"floating_flag":false,"issued_shares_note":null,"nom_ccy":null,"eff_gear":"","board_lot_nominal":null,"hsic_ind_classification":"Healthcare - Pharmaceuticals & Biotechnology","ew_desc":null,"inception_date":"","nc":"-0.120","aum":"","issued_shares_class_B":null,"vo":"9.74","secondary_listing_flag":false,"listing_date":"12 Nov 2019","issued_shares_class_A":null,"as_at_label":"as at","ew_amt_os_dat":"","nm":"SinoMab BioScience Ltd. - B","nm_s":"SINOMAB BIO-B","sym":"3681","inline_lower_strike_price":"","listing_category":"Primary Listing","ew_strike_cur":null,"exotic_warrant_indicator":null,"investment_focus":null,"call_price":"","tck":"0.010","strike_price":"","summary":"SinoMab BioScience Ltd is a Hong Kong-based biopharmaceutical company mainly dedicated to the research, development, manufacturing and commercialization of therapeutics for the treatment of immunological diseases. The Company primarily develops mAb-based biologics and new chemical entities (NCE). The Company’s product SM03 is a mAb for the treatment of rheumatoid arthritis (RA). The Company is developing drugs for the treatment of RA, systemic lupus erythematosus (SLE), asthma, pemphigus, sjogren’s syndrome (SS) and other immunological diseases.","op":"1.880","aum_u":"","nav_ccy":null,"class_B_description":null,"os":"","wnt_gear":"","transfer_of_listing_date":"","hsic_sub_sector_classification":"Biotechnology","amt_ccy":null,"class_A_description":null,"domicile_country":null,"entitlement_ratio":"","product_type":"EQTY","office_address":"Units 303 and 305 to 307<br/>No.15 Science Park West Avenue<br/>Hong Kong Science Park<br/>Pak Shek Kok, NT, Hong Kong","pc":"-6.38","days_to_expiry":null,"underlying_code":null,"pe":"","eps_ccy":"RMB","hdr":false,"launch_date":"","hc":"1.880","isin":"HK0000544194","moneyness":""}},"qid":"1758890338053"}
